Antimicrobial drug pathogen list
Executive Summary
On March 5, FDA's Anti-Infective Drugs Advisory Committee will discuss important pathogens list for antimicrobial drug development and how preclinical and clinical data from one disease may support approval of antimicrobial drugs in a separate disease. Industry urged development of a list at a meeting on encouraging antibiotic development (1"The Pink Sheet" Nov. 25, 2002, p. 18). [To 2sign up for a webcast or video of this or other advisory committee meetings, visit FDAAdvisoryCommittee.com]...
On March 5, FDA's Anti-Infective Drugs Advisory Committee will discuss important pathogens list for antimicrobial drug development and how preclinical and clinical data from one disease may support approval of antimicrobial drugs in a separate disease. Industry urged development of a list at a meeting on encouraging antibiotic development (1 , p. 18). [To 2 sign up for a webcast or video of this or other advisory committee meetings, visit FDAAdvisoryCommittee.com].... |